1719. In Vitro Activity of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and Pseudomonas aeruginosa Collected from Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2017-2020

BACKGROUND: Avibactam (AVI) is a β-lactamase inhibitor with potent inhibitory activity against Class A, Class C, and some Class D serine β-lactamases. The use of ceftazidime (CAZ) with AVI is approved for several indications. This study evaluated the in vitro activity of CAZ-AVI and comparators agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Estabrook, Mark, Stone, Gregory, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752578/
http://dx.doi.org/10.1093/ofid/ofac492.1349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752578/
http://dx.doi.org/10.1093/ofid/ofac492.1349

Ejemplares similares